We thank Dumont and Black1 for further raising the issue of the need for effective contraception in order to prevent pregnancies during isotretinoin treatment.
Our report2 included only the typical-use contraception failure rates. Please note that Box 1 in our manuscript provides the same typical-use failure rates as reported by Trussell and colleagues and quoted by Dumont and Black.2
References
- 1.Dumont T, Black A. Pregnancy and isotretinoin therapy [letter]. CMAJ 2013;185:508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Choi JS, Koren G, Nulman I. Pregnancy and isotretinoin therapy. CMAJ 2013;185:411–13 [DOI] [PMC free article] [PubMed] [Google Scholar]